Harm Reduction Journal

Table 2 Proportion of respondents reporting use of smokeless tobacco, any stop-smoking medication, and nicotine replacement therapy within each country (%; weighted)

From: Trends in beliefs about the harmfulness and use of stop-smoking medications and smokeless tobacco products among cigarettes smokers: Findings from the ITC four-country survey

	2002	2003	2004	2005	2006	2007	2008
Used SLT in last 12 months
Canada	2.5	1.3	2.3	2.3	2.0	2.4	2.3
US	6.4	4.6	5.5	6.8	6.0	7.6	6.2
UK	2.2	1.6	1.7	1.7	1.9	2.1	1.9
Australia	1.9	1.0	1.7	1.0	1.6	1.0	1.4
χ²	χ² = 93.5**	χ² = 77.2**	χ² = 68.6**	χ² = 127.7**	χ² = 83.7**	χ² = 145.8**	χ² = 73.7**
Used any SSM in last 12 months
Canada	16.5	15.4	18.7	18.1	20.3	21.5	22.0
US	11.9	10.5	12.2	16.5	15.5	20.5	21.4
UK	12.7	11.8	16.7	22.2	23.2	21.3	21.6
Australia	16.1	14.1	16.6	18.2	22.3	22.3	22.0
χ²	χ² = 28.9**	χ² = 25.2**	χ² = 31.4**	χ² = 20.0**	χ² = 38.2**	χ² = 1.7	χ² = 0.2
Used NRT in last 12 months
Canada	13.1	11.9	15.4	15.9	17.8	17.1	13.4
US	8.8	7.4	9.0	12.7	12.6	13.1	11.0
UK	11.7	11.3	15.8	21.4	22.4	19.2	17.8
Australia	13.4	12.3	14.8	15.9	20.0	18.9	15.6
χ²	χ² = 27.8**	χ² = 30.1**	χ² = 50.2**	χ² = 50.1**	χ² = 61.6**	χ² = 28.7**	χ² = 30.8**

NB: SLT = Smokeless tobacco, ST = Smoked tobacco, & NRT = Nicotine replacement therapy, & SSM = Stop smoking medication. ** = p < 0.01.

Back to article page

ISSN: 1477-7517

Contact us

Submission enquiries: journalsubmissions@springernature.com